{
    "url_original": "https://www.wsj.com/articles/activist-investors-take-aim-at-u-k-inc-11643797427?mod=markets_lead_pos3",
    "url": "activist-investors-take-aim-at-u-k-inc-11643797427",
    "title": "Activist Investors Take Aim at U.K. Inc.",
    "sub_head": "Elliott Management, Third Point and Trian Fund Management are among the firms pushing for changes at big U.K. companies",
    "category_1": "Markets",
    "image_1_url": "https://images.wsj.net/im-478015?width=860&height=573",
    "image_1": "im-478015.jpg",
    "time": "2022-02-02 05:30:00",
    "body": "U.S. and European activist investors are targeting some of the U.K.’s biggest publicly traded companies, taking advantage of slumping stock prices to push for company breakups and other changes.<br />Florida-based hedge fund Elliott Management Corp. is making waves at U.K. pharmaceutical giant  GlaxoSmithKline PLC  and  SSE PLC ,  an electricity network and alternative energy provider. Daniel Loeb’s Third Point LLC is calling for a breakup of  Shell PLC .  And Trian Fund Management LP, another well-known U.S. activist hedge fund, headed by Nelson Peltz, owns a stake in  Unilever PLC ,  The Wall Street Journal reported last month."
}